Elevance Health, Inc. (NYSE:ELV) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Fri, Aug 22, 2025, 7:00 AM 4 min read

With its stock down 17% over the past three months, it is easy to disregard Elevance Health (NYSE:ELV). But if you pay close attention, you might gather that its strong financials could mean that the stock could potentially see an increase in value in the long-term, given how markets usually reward companies with good financial health. Specifically, we decided to study Elevance Health’s ROE in this article.

Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors’ money. In short, ROE shows the profit each dollar generates with respect to its shareholder investments.

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

The formula for ROE is:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders’ Equity

So, based on the above formula, the ROE for Elevance Health is:

12% = US$5.3b ÷ US$44b (Based on the trailing twelve months to June 2025).

The ‘return’ is the profit over the last twelve months. One way to conceptualize this is that for each $1 of shareholders’ capital it has, the company made $0.12 in profit.

View our latest analysis for Elevance Health

Thus far, we have learned that ROE measures how efficiently a company is generating its profits. We now need to evaluate how much profit the company reinvests or “retains” for future growth which then gives us an idea about the growth potential of the company. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don’t have the same features.

At first glance, Elevance Health seems to have a decent ROE. Even when compared to the industry average of 12% the company’s ROE looks quite decent. Elevance Health’s decent returns aren’t reflected in Elevance Health’smediocre five year net income growth average of 3.9%. So, there could be some other factors at play that could be impacting the company’s growth. For instance, the company pays out a huge portion of its earnings as dividends, or is faced with competitive pressures.

Next, on comparing with the industry net income growth, we found that Elevance Health’s growth is quite high when compared to the industry average growth of 2.9% in the same period, which is great to see.